Ledger.Open graph →

SEC Form D · Amendment · filed January 19, 2016

Cingulate Therapeutics

Offering

—

Sold

$75K

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

MORRISTOWN, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Patrick J. Gallagher · Flanders, NJDirector Craig S. Gilgallon · Morristown, NJExec Arthur B. Straughn · Cordova, TNDirector Laurie A. Myers · Lawrenceville, NJDirector Raul R. Silva · Tenefly, NJExec Craig S. Tashjy · chester, NJExec Matthew N. Brams · Houston, TXDirector Shane J. Schaffer · Morristown, NJExec William P. Phelan · Albany, NYExec Frederick W. Jones · Albany, NYDirector Thomas J. Marusak · Albany, NYDirector Swapnil Agarwal · HOUSTON, TXExec McB Kh, LLC · Longview, TXExec Jeff Kellam · Longview, TXDirector David C. Michaels · Albany, NYDirector Timothy Harrington · Rowayton, CTExec George A. Overholser · KIRKLAND, WAExec · Director William A. Ruckelshaus · KIRKLAND, WAExec John H. Cox · Schaumburg, ILExec Arrun Kapoor · Durham, NCDirector David Griest · Durham, NCDirector Alan Kelley · Durham, NCDirector David Kirkpatrick · Durham, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗